Finance

Senarai
DVAI34:BVMF
Davita Inc BDR
R$1,044.32
0.00%
(0.00) 1H
6 Nov, 4:56:00 PTG GMT-3  ·   BRL
Semua simbol
SimbolHargaPerubahan% Perubahan
Menjana cerapan popular untuk DVAI34...
Buka
R$1,047.53
Tinggi
R$1,047.53
Rendah
R$1,044.32
Permodalan Pasaran
12.04B
Purata volum
11.00
Volum
4.00
tgi 52 mgu
R$1,253.26
rdh 52 mgu
R$546.63
Syer tertunggak
62.90J
Bilangan pekerja
78K
Buka
R$1,047.53
Tinggi
R$1,047.53
Rendah
R$1,044.32
Permodalan Pasaran
12.04B
Purata volum
11.00
Volum
4.00
tgi 52 mgu
R$1,253.26
rdh 52 mgu
R$546.63
Syer tertunggak
62.90J
Bilangan pekerja
78K
Cerita berita
Daripada sumber web dan rakan kongsi berita
Profil
DaVita Inc. is an American health care company, incorporated in Delaware and headquartered in Denver, that provides kidney dialysis services through a network of 2,657 outpatient centers in the United States. DaVita serves 200,500 patients, and has 585 outpatient centers in 14 other countries serving 94,500 patients. The company primarily treats end-stage renal disease, which requires patients to undergo kidney dialysis, often 3 times per week for the rest of their lives unless they receive a kidney transplant via organ donation. In 2025, 68% of the company's revenues came from Medicare and other government-based health insurance programs. In 2025, 89% of the company's patients were covered by government-based health insurance programs. Commercial payers, which accounted for 32% of revenues in 2025, generate nearly all of the company's profit as they reimburse at a much higher rate than government-based health insurance programs. The company is ranked 331st on the 2026 Fortune 500. Wikipedia
Perihal Davita Inc BDR
CEOJavier J. Rodriguez
Pekerja78K
Diasaskan1992
Ibu pejabatDenver, Colorado, Amerika Syarikat
SektorHealth Care
Industri-
Laman webdavita.com
Laporan sebelumnyaSemua nilai dalam USD
Loading Previous Earnings...
Hasil
Pendapatan bersih
Semua nilai dalam USD
Dis 2025
Mac 2026
Jun 2026
Sep 2026
Hasil
3.62B
3.42B
3.55B
3.58B
Kos barangan yang dijual
2.41B
2.34B
2.39B
2.45B
Kos hasil
2.41B
2.34B
2.39B
2.45B
Perbelanjaan penyelidikan dan pembangunan
-
-
-
-
Jumlah perbelanjaan penyelidikan dan pembangunan
-
-
-
-
Perbelanjaan jualan, am dan pentadbiran
472.36J
421.91J
423.46J
408.70J
Belanja kendalian
659.06J
599.74J
591.27J
573.88J
Jumlah belanja kendalian
3.07B
2.94B
2.98B
3.02B
Pendapatan kendalian
551.20J
473.55J
570.82J
553.19J
Pendapatan bukan kendalian lain
-21.03J
639.00K
4.47J
5.63J
EBT termasuk item luar biasa
382.76J
341.23J
435.01J
358.71J
EBT tidak termasuk item luar biasa
391.79J
341.23J
437.04J
420.88J
Belanja cukai pendapatan
76.73J
66.20J
91.79J
89.32J
Kadar cukai berkesan
20.05%
19.40%
21.10%
24.90%
Belanja kendalian lain
-
-
-
-
Pendapatan bersih
234.22J
197.53J
265.40J
222.93J
Margin untung bersih
6.47%
5.78%
7.47%
6.23%
Perolehan bagi setiap syer
3.40
2.87
4.02
3.82
Pendapatan faedah dan pelaburan
-
-
-
-
Belanja faedah
-148.25J
-141.30J
-146.42J
-146.18J
Belanja faedah bersih
-148.25J
-141.30J
-146.42J
-146.18J
Caj susut nilai dan pelunasan
186.70J
177.83J
167.81J
165.19J
EBITDA
737.91J
651.38J
738.62J
718.38J
Keuntungan atau kerugian daripada jualan aset
-17.55J
-
-
-
Acara akan datang
Kandungan AI boleh mengandungi kesilapan. Ketahui lebih lanjut
BantuanHantar maklum balasPrivasiSyaratPenafian
Apl Google